The research team used a sophisticated sampling strategy that enabled the true performance of the polygenic risk score to be determined and not be influenced by the effects of age and sex.
New polygenic risk scores for obesity, type 2 diabetes, and related complications developed by researchers at Mass General Brigham have effectively identified at-risk individuals. Increasing ...
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer The PRS is useful in determining second ...
MENLO PARK, Calif., Sept. 3, 2025 /PRNewswire/ -- MyOme, a leading clinical whole genome testing and polygenic risk modelling (PRS) company, today announced the launch of its Type 2 Diabetes (T2D) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results